Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Antiepileptic drugs can cause cosmetic side effects and affect menstrual cycles, fertility, and bone health in women with epilepsy.

Oral minoxidil may slow male pattern baldness and cause body hair growth, but hair loss can happen after stopping it.

Hair restoration combines drugs and follicular unit grafting for natural, long-lasting results.

Dissolving microneedles with finasteride improve drug delivery for hair loss treatment.

Fludalanine failed as an effective oral antibiotic despite efforts.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Desmopressin-loaded liposomes can effectively deliver drugs through the skin, improving bioavailability and patient compliance.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Some medications caused temporary health issues that improved after stopping the drugs, but two patients died from liver problems linked to carbamazepine.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Solid lipid nanoparticles are promising for delivering various drugs and improving treatment effectiveness.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

A man developed a skin reaction from metronidazole, which improved after stopping the drug and starting steroids.

Hair restoration can cause severe seizures due to combined drug toxicity.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

A bald man grew hair on his head after taking a drug called diazoxide, but lost it again when he stopped the medication.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Nail loss may be a side effect of the MS drug teriflunomide.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Hydrogels have great potential for improving wound care, drug delivery, and tissue engineering in veterinary medicine.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Skin pigmentation varies due to genetics, UV exposure, and drugs, with treatments available but requiring medical advice.